OrbiMed Advisors LLC is a leading healthcare investment firm based in New York City, specializing in public and private investments across the healthcare and biotechnology sectors. Founded in 1998 by Samuel Isaly, Michael Sheffery, and Arvind Desai, OrbiMed has grown to become one of the world's largest dedicated healthcare investment firms, managing approximately $17 billion in assets as of March 2024. The firm's investment approach spans various stages of company development, from seed-stage startups to large multinational corporations, focusing on biopharmaceuticals, medical devices, diagnostics, and technology-enabled healthcare services.

OrbiMed's global team of over 130 professionals operates across multiple locations, including New York City, London, San Francisco, Shanghai, Hong Kong, Mumbai, and Herzliya, enabling the firm to provide tailored financing solutions and extensive resources to its portfolio companies. Notable achievements include raising over $4.3 billion across three private investment funds in October 2023, demonstrating strong investor confidence and the firm's commitment to driving innovation in the healthcare sector. Additionally, in May 2023, OrbiMed expanded its presence in Europe by opening a London office, further solidifying its position in the global healthcare investment landscape.